Is JD Health International Inc. a good investment? JD Health International Inc. (6618.HK) is currently trading at 39.80 HKD. Market analysts have a consensus price target of 68.71 HKD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 17.93. This valuation is generally in line with the broader market.
Earnings Schedule: JD Health International Inc. is expected to release its next earnings report on March 29, 2027. The market consensus estimate for Forward EPS is 2.95.
No, it does not currently pay a dividend.
JD Health International Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be March 29, 2027. The company currently has a trailing EPS of 2.17.
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Community Discussion